Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.52% | 18.48% | 19.59% | 17.49% | 15.10% |
| Total Depreciation and Amortization | -16.00% | -0.38% | 1.61% | 3.41% | 3.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.94% | -18.61% | -22.36% | -14.80% | -3.49% |
| Change in Net Operating Assets | 53.36% | 69.03% | 42.04% | 36.02% | -59.29% |
| Cash from Operations | 24.21% | 24.57% | 22.68% | 21.35% | 15.42% |
| Capital Expenditure | 70.85% | 39.71% | 37.86% | 12.13% | 28.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.25% | 2,529.92% | 366.19% | -4.52% | -22.96% |
| Cash from Investing | 20.94% | 4,858.71% | 351.88% | -4.28% | -22.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.41% | 128.03% | 6.86% | 6.19% | -0.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.67% | 127.03% | 5.86% | 5.20% | -0.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 567.98% | 331.19% | 164.81% | 126.03% | 55.28% |